Literature DB >> 25911169

Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.

Zhichao Zhou1, Uthra Rajamani, Hicham Labazi, Stephen L Tilley, Catherine Ledent, Bunyen Teng, S Jamal Mustafa.   

Abstract

Adenosine increases coronary flow mainly through the activation of A2A and A2B adenosine receptors (ARs). However, the mechanisms for the regulation of coronary flow are not fully understood. We previously demonstrated that adenosine-induced increase in coronary flow is in part through NADPH oxidase (Nox) activation, which is independent of activation of either A1 or A3ARs. In this study, we hypothesize that adenosine-mediated increase in coronary flow through Nox activation depends on A2A but not A2BARs. Functional studies were conducted using isolated Langendorff-perfused mouse hearts. Hydrogen peroxide (H2O2) production was measured in isolated coronary arteries from WT, A2AAR knockout (KO), and A2BAR KO mice using dichlorofluorescein immunofluorescence. Adenosine-induced concentration-dependent increase in coronary flow was attenuated by the specific Nox2 inhibitor gp91 ds-tat or reactive oxygen species (ROS) scavenger EUK134 in both WT and A2B but not A2AAR KO isolated hearts. Similarly, the A2AAR selective agonist CGS-21680-induced increase in coronary flow was significantly blunted by Nox2 inhibition in both WT and A2BAR KO, while the A2BAR selective agonist BAY 60-6583-induced increase in coronary flow was not affected by Nox2 inhibition in WT. In intact isolated coronary arteries, adenosine-induced (10 μM) increase in H2O2 formation in both WT and A2BAR KO mice was attenuated by Nox2 inhibition, whereas adenosine failed to increase H2O2 production in A2AAR KO mice. In conclusion, adenosine-induced increase in coronary flow is partially mediated by Nox2-derived H2O2, which critically depends upon the presence of A2AAR.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911169      PMCID: PMC4425720          DOI: 10.1007/s11302-015-9451-x

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  65 in total

Review 1.  Structure and function of adenosine receptors and their genes.

Authors:  B B Fredholm; G Arslan; L Halldner; B Kull; G Schulte; W Wasserman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

2.  Adenosine can mediate its actions through generation of reactive oxygen species.

Authors:  Debebe Gebremedhin; Brian Weinberger; David Lourim; David R Harder
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-09       Impact factor: 6.200

Review 3.  The Nox family of NADPH oxidases: friend or foe of the vascular system?

Authors:  Ina Takac; Katrin Schröder; Ralf P Brandes
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 4.  Mechanisms of metabolic coronary flow regulation.

Authors:  Andreas Deussen; Vahagn Ohanyan; Anett Jannasch; Liya Yin; William Chilian
Journal:  J Mol Cell Cardiol       Date:  2011-10-08       Impact factor: 5.000

Review 5.  Purinergic signaling and blood vessels in health and disease.

Authors:  Geoffrey Burnstock; Vera Ralevic
Journal:  Pharmacol Rev       Date:  2013-12-11       Impact factor: 25.468

6.  NADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice.

Authors:  Mohammed S El-Awady; Habib R Ansari; Daniel Fil; Stephen L Tilley; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2011-05-23       Impact factor: 4.030

7.  Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species.

Authors:  Jun Feng; Scott M Damrauer; Monica Lee; Frank W Sellke; Christiane Ferran; Md Ruhul Abid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-11       Impact factor: 8.311

8.  Role of NOX2 in the regulation of afferent arteriole responsiveness.

Authors:  Mattias Carlström; En Yin Lai; Zufu Ma; Andreas Patzak; Russell D Brown; A Erik G Persson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-11-05       Impact factor: 3.619

9.  Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo.

Authors:  Toyotaka Yada; Hiroaki Shimokawa; Osamu Hiramatsu; Yoshiro Shinozaki; Hidezo Mori; Masami Goto; Yasuo Ogasawara; Fumihiko Kajiya
Journal:  J Am Coll Cardiol       Date:  2007-09-10       Impact factor: 24.094

10.  Evidence for the involvement of NADPH oxidase in adenosine receptors-mediated control of coronary flow using A1 and A3 knockout mice.

Authors:  Mohammed S El-Awady; Uthra Rajamani; Bunyen Teng; Stephen L Tilley; S Jamal Mustafa
Journal:  Physiol Rep       Date:  2013-08-01
View more
  10 in total

Review 1.  Kv1.3 channels facilitate the connection between metabolism and blood flow in the heart.

Authors:  Vahagn Ohanyan; Liya Yin; Raffi Bardakjian; Christopher Kolz; Molly Enrick; Tatevik Hakobyan; Jordan Luli; Kathleen Graham; Mohamed Khayata; Suzanna Logan; John Kmetz; William M Chilian
Journal:  Microcirculation       Date:  2017-05       Impact factor: 2.628

2.  Small molecule compound M12 reduces vascular permeability in obese mice via blocking endothelial TRPV4-Nox2 interaction.

Authors:  Meng-Ru Gao; Peng Zhang; Jing Han; Chun-Lei Tang; Yi-Fei Zhu; Hao Kan; Hong-Juan Li; Xi-Ping Han; Xin Ma
Journal:  Acta Pharmacol Sin       Date:  2021-10-15       Impact factor: 7.169

3.  Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation.

Authors:  Vahagn Ohanyan; Liya Yin; Raffi Bardakjian; Christopher Kolz; Molly Enrick; Tatevik Hakobyan; John Kmetz; Ian Bratz; Jordan Luli; Masaki Nagane; Nadeem Khan; Huagang Hou; Periannan Kuppusamy; Jacqueline Graham; Frances Kwan Fu; Danielle Janota; Moses O Oyewumi; Suzanna Logan; Jonathan R Lindner; William M Chilian
Journal:  Circ Res       Date:  2015-07-29       Impact factor: 17.367

4.  Enhanced A1 adenosine receptor-induced vascular contractions in mesenteric artery and aorta of in L-NAME mouse model of hypertension.

Authors:  Vishal R Yadav; Bunyen Teng; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2018-10-19       Impact factor: 4.432

5.  Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice.

Authors:  Bunyen Teng; Hicham Labazi; Changyan Sun; Yan Yang; Xiaorong Zeng; S Jamal Mustafa; Zhichao Zhou
Journal:  Purinergic Signal       Date:  2017-09-20       Impact factor: 3.765

6.  Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases.

Authors:  Rosario Ammendola; Melania Parisi; Gabriella Esposito; Fabio Cattaneo
Journal:  Antioxidants (Basel)       Date:  2021-01-19

Review 7.  Adenosine and adenosine receptor-mediated action in coronary microcirculation.

Authors:  Ying Zhang; Bernhard Wernly; Xin Cao; S Jamal Mustafa; Yong Tang; Zhichao Zhou
Journal:  Basic Res Cardiol       Date:  2021-03-23       Impact factor: 17.165

8.  Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids.

Authors:  Zhichao Zhou; Inge M Lankhuizen; Heleen M van Beusekom; Caroline Cheng; Dirk J Duncker; Daphne Merkus
Journal:  Front Pharmacol       Date:  2018-03-26       Impact factor: 5.810

9.  Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury.

Authors:  Eric Y Shin; Lanfang Wang; Marina Zemskova; Juline Deppen; Kai Xu; Frederick Strobel; Andrés J García; Rabindra Tirouvanziam; Rebecca D Levit
Journal:  J Am Heart Assoc       Date:  2018-01-13       Impact factor: 5.501

10.  CD73+ extracellular vesicles inhibit angiogenesis through adenosine A2B receptor signalling.

Authors:  Roberta Angioni; Cristina Liboni; Stephanie Herkenne; Ricardo Sánchez-Rodríguez; Giulia Borile; Elisabetta Marcuzzi; Bianca Calì; Maurizio Muraca; Antonella Viola
Journal:  J Extracell Vesicles       Date:  2020-05-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.